Literature DB >> 25976461

Ames hypopituitary dwarf mice demonstrate imbalanced myelopoiesis between bone marrow and spleen.

Maegan L Capitano1, Brahmananda R Chitteti2, Scott Cooper1, Edward F Srour2, Andrzej Bartke3, Hal E Broxmeyer4.   

Abstract

Ames hypopituitary dwarf mice are deficient in growth hormone, thyroid-stimulating hormone, and prolactin. The phenotype of these mice demonstrates irregularities in the immune system with skewing of the normal cytokine milieu towards a more anti-inflammatory environment. However, the hematopoietic stem and progenitor cell composition of the bone marrow (BM) and spleen in Ames dwarf mice has not been well characterized. We found that there was a significant decrease in overall cell count when comparing the BM and spleen of 4-5 month old dwarf mice to their littermate controls. Upon adjusting counts to differences in body weight between the dwarf and control mice, the number of granulocyte-macrophage progenitors, confirmed by immunophenotyping and colony-formation assay was increased in the BM. In contrast, the numbers of all myeloid progenitor populations in the spleen were greatly reduced, as confirmed by colony-formation assays. This suggests that there is a shift of myelopoiesis from the spleen to the BM of Ames dwarf mice; however, this shift does not appear to involve erythropoiesis. The reasons for this unusual shift in spleen to marrow hematopoiesis in Ames dwarf mice are yet to be determined but may relate to the decreased hormone levels in these mice.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Ames dwarf mice; Growth hormone; Hematopoietic progenitor cell; Prolactin; Thyroid-stimulating hormone

Mesh:

Substances:

Year:  2015        PMID: 25976461      PMCID: PMC4433494          DOI: 10.1016/j.bcmd.2015.03.004

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  43 in total

1.  Primary B cell development is impaired in mice with defects of the pituitary/thyroid axis.

Authors:  E Montecino-Rodriguez; R G Clark; L Powell-Braxton; K Dorshkind
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

2.  Effects of growth hormone and thyroxine replacement therapy on insulin signaling in Ames dwarf mice.

Authors:  Audreen Louis; Andrzej Bartke; Michal M Masternak
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-03       Impact factor: 6.053

Review 3.  Genes that prolong life: relationships of growth hormone and growth to aging and life span.

Authors:  A Bartke; K Coschigano; J Kopchick; V Chandrashekar; J Mattison; B Kinney; S Hauck
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-08       Impact factor: 6.053

4.  Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor I.

Authors:  S Merchav; I Tatarsky; Z Hochberg
Journal:  Br J Haematol       Date:  1988-11       Impact factor: 6.998

5.  T and B lymphocytes in pituitary dwarf Snell-Bagg mice.

Authors:  F Dumont; F Robert; P Bischoff
Journal:  Immunology       Date:  1979-09       Impact factor: 7.397

6.  Comparative studies of the granulopoietic enhancing effects of biosynthetic human insulin-like growth factors I and II.

Authors:  S Merchav; M Lake; A Skottner
Journal:  J Cell Physiol       Date:  1993-10       Impact factor: 6.384

7.  In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation.

Authors:  P Jardieu; R Clark; D Mortensen; K Dorshkind
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

8.  Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures.

Authors:  M Sanders; S Sorba; N Dainiak
Journal:  Exp Hematol       Date:  1993-01       Impact factor: 3.084

9.  Homeostatic and pathogenic extramedullary hematopoiesis.

Authors:  Chang H Kim
Journal:  J Blood Med       Date:  2010-03-23

10.  Growth hormone, inflammation and aging.

Authors:  Michal M Masternak; Andrzej Bartke
Journal:  Pathobiol Aging Age Relat Dis       Date:  2012-04-04
View more
  3 in total

Review 1.  Mouse models of growth hormone deficiency.

Authors:  Edward O List; Reetobrata Basu; Silvana Duran-Ortiz; Jackson Krejsa; Elizabeth A Jensen
Journal:  Rev Endocr Metab Disord       Date:  2020-10-09       Impact factor: 6.514

2.  Growth hormone-mediated reprogramming of macrophage transcriptome and effector functions.

Authors:  Augusto Schneider; Hillary N Wood; Sandra Geden; Catherine J Greene; Robin M Yates; Michal M Masternak; Kyle H Rohde
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

Review 3.  Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?

Authors:  Hal E Broxmeyer; Yan Liu; Reuben Kapur; Christie M Orschell; Arafat Aljoufi; James P Ropa; Thao Trinh; Sarah Burns; Maegan L Capitano
Journal:  Stem Cell Rev Rep       Date:  2020-11-03       Impact factor: 5.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.